Showing results (21-30 of 68) with videos related to
Sort By:
Pageof 7
The American Journal of Pediatric Hematology/Oncology|January 1, 1989
Acquired immune deficiency, myelodysplasia, and acute nonlymphocytic leukemia associated with monosomy 7 and t(3;3) (q21;q26) in a child with Langerhans cell histiocytosisD H Mahoney, K L McClain, I C Hanson, et al.Cancer|September 1, 1987
Malignant rhabdoid tumor of the extremityA L Kent, D H Mahoney, M V Gresik, et al.The American Journal of Pediatric Hematology/Oncology|January 1, 1991
Essential thrombocythemia in a child: management with anagrelideM M Chintagumpala, C P Steuber, D H Mahoney, et al.Medical and Pediatric Oncology|January 1, 1984
Combination chemotherapy with vincristine (NSC-67574), procarbazine (NSC-77213), prednisone (NSC-10023) with or without nitrogen mustard (NSC-762)(MOPP vs OPP) in children with recurrent brain tumorsA Cangir, A H Ragab, P Steuber, et al.Medical and Pediatric Oncology|January 11, 1992
Soft-tissue sarcomas other than rhabdomyosarcoma in childrenA Hayani, D H Mahoney, H K Hawkins, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II studyC P Steuber, J Krischer, T Holbrook, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trialD H Mahoney, J Shuster, R Nitschke, et al.Medical and Pediatric Oncology|January 1, 1976
Acute leukemia in Burkitt lymphomaR L Heideman, J M Falletta, P Steuber, et al.Investigational New Drugs|December 1, 1987
Toxicity evaluation of dihydroxyanthracenedione (DHAD) in combination with cytosine arabinoside (Ara-C)C P Steuber, V J Land, C I Civin, et al.Medical and Pediatric Oncology|January 1, 1978
Use of L-asparaginase and cytosine arabinoside for refractory acute lymphocytic leukemia with particular reference to T-cell leukemiaC P Steuber, G J Levy, W L Nix, et al.Pageof 7